- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01572233
Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection
December 26, 2012 updated by: National Taiwan University Hospital
Effects of Personalized Physical Activity and Psycho-Education Program on Patients With Chronic Hepatitis C Infection
This 4-year project will be guided by a biobehavioral model for the study of exercise interventions in two phases with the purposes to :
- explore the patients' physical activity preferences and develop doable activity lists during treatment period
- examine the changes of health-related physical fitness component over interferon treatment
- develop the Personalized Physical Activity and Psych-Education (PPAPE) Program and test its effects on decreasing fatigue, physical and psychological distress, and improving their health-related physical fitness and quality of life in patients with chronic hepatitis C receiving Interferon with Ribavirin Combination Therapy
- evaluate the outcome of the PPAPE program on increasing adherence to therapy, the sustained virological response (SVR) in 24 weeks after the end of treatment, and the time-consuming for education program during intervention.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with Chronic Hepatitis C Infection Receiving Interferon Therapy
- Aged above 18
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patient with HCV Infection
Personalized Physical Activity and Psycho-Education (PPAPE) Program will be tested on this group.
|
|
|
No Intervention: usual care
waiting list group with usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effects of Activity and Education Program on Patients with Chronic Hepatitis C Infection
Time Frame: 4-year project
|
Phase I of this project, the first and second year, the measurement time will be collected on the baseline (before treatment, T0), the 8 weeks (T1), 16 weeks (T2), and 24 weeks (T3) during treatment.
|
4-year project
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (Anticipated)
December 1, 2017
Study Completion (Anticipated)
June 1, 2018
Study Registration Dates
First Submitted
April 4, 2012
First Submitted That Met QC Criteria
April 4, 2012
First Posted (Estimate)
April 6, 2012
Study Record Updates
Last Update Posted (Estimate)
December 27, 2012
Last Update Submitted That Met QC Criteria
December 26, 2012
Last Verified
November 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- RNA Virus Infections
- Blood-Borne Infections
- Disease Attributes
- Liver Diseases
- Flaviviridae Infections
- Hepatitis, Viral, Human
- Enterovirus Infections
- Picornaviridae Infections
- Hepatitis, Chronic
- Infections
- Communicable Diseases
- Hepatitis
- Hepatitis A
- Hepatitis C
- Virus Diseases
- Hepatitis C, Chronic
Other Study ID Numbers
- 201103086RC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hepatitis C Virus Infection, Response to Therapy of
-
Johns Hopkins UniversityAbbVieCompletedHepatitis C Virus Infection, Response to Therapy ofUnited States, Canada
-
National Taiwan University HospitalRecruitingHepatitis C Virus Infection | Hemodialysis Complication | Hepatitis C Virus Infection, Response to Therapy ofTaiwan
-
University of California, San DiegoCompletedHepatitis C | Hepatitis C Virus Infection, Response to Therapy ofUnited States
-
Akros Pharma Inc.CompletedHepatitis C Virus Infection, Response to Therapy ofPuerto Rico
-
Kawin Technology Share-holding Co., Ltd.KawinGreen Biotech Co., Ltd.CompletedHepatitis C, Chronic | Hepatitis C Virus Infection, Response to Therapy ofChina
-
Egyptian Liver HospitalUnknownHepatitis C Virus Infection, Response to Therapy ofEgypt
-
Hasselt UniversityJessa Hospital; Ziekenhuis Netwerk Antwerpen (ZNA); Ziekenhuis Oost-Limburg; Algemeen... and other collaboratorsRecruitingDrug Use | Hepatitis C Virus Infection, Response to Therapy ofBelgium
-
University of Maryland, BaltimoreMerck Sharp & Dohme LLC; Cairo UniversityWithdrawnHepatitis C Virus Infection, Response to Therapy ofEgypt
-
National Taiwan University HospitalRecruitingHepatitis C Virus Infection | Hepatitis C Virus Infection, Response to Therapy of | Human Immunodeficiency Virus (HIV) CoinfectionTaiwan
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)CompletedHuman Immunodeficiency Virus | Hepatitis C Virus Infection, Response to Therapy ofUnited States
Clinical Trials on Personalized Physical Activity and Psycho-Education (PPAPE) Program
-
Swedish Red Cross University CollegeSwedish Red CrossCompletedPTSD | Physical Activity | Depression, AnxietySweden
-
University Hospital, Clermont-FerrandLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques... and other collaboratorsUnknownParkinson's DiseaseFrance
-
Case Western Reserve UniversityNational Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
University of BrawijayaUniversiti Putra Malaysia; Universiti Teknologi MARA (UiTM) Sungai Buloh Campus...CompletedBody Composition | Nutrition | Obesity Prevention | Workplace Interventions | Wellness ProgramIndonesia
-
Hospices Civils de LyonCompleted
-
Gadjah Mada UniversityUniversitas Islam Indonesia; Faculty of Medicine, Gadjah Mada UniversityCompleted
-
University of North Carolina, Chapel HillNational Institute on Minority Health and Health Disparities (NIMHD)CompletedPhysical Activity | Vascular Stiffness | Health Behavior | Cardiovascular Risk Factor | Self EfficacyUnited States
-
University of ManitobaVictoria General Hospital FoundationUnknownQuality of Life | Obesity | Exercise | Bariatric Surgery | Roux-En-Y Gastric BypassCanada
-
Universidad Santo TomasEmory University; Universidad Pública de Navarra; Universidad de Granada; University... and other collaboratorsCompletedObesity | Lipid Metabolism Disorders | Mental Health Wellness 1 | Body Composition, Beneficial | Metabolic Syndrome X
-
University of Vic - Central University of CataloniaThe Social Services AdministrationCompletedPromotion of Healthy Eating Habits and Physical Activity Among Children and Their Families. (ALIAFF)Physical Activity | Children | Food Habits | FamiliesSpain